First Human Receives Neuralink Brain Implant, Raising Hopes and Concerns
What You Should Know:
- Elon Musk's brain-computer interface (BCI) company, Neuralink, announced a major milestone on Monday: the first human patient has successfully received a Neuralink implant and is recovering well.
- The successful implantation and promising initial results represent a significant step for Neuralink. However, addressing ethical concerns, ensuring transparency, and rigorously evaluating safety
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Peloton Equity Invests in OnPoint Healthcare to Combat Physician Burnout with AI
What You Should Know:
- Peloton Equity, a private equity firm focused on healthcare growth companies, announced a significant investment in OnPoint Healthcare Partners, a leader in AI-powered solutions for reducing physician burnout and improving administrative efficiencies.
- This partnership aims to empower OnPoint to accelerate its growth and impact on healthcare delivery. With the investment, Peloton representatives and Michael Clark, President of RAAPID.AI, will join OnPoint's board
Read More
Valendo Health Launches with $4M for Value-Based Endocrinology to Improve Diabetes Care
What You Should Know:
Valendo Health, a value-based endocrinology company, officially launched today with a mission to empower endocrinologists to shape the future of diabetes care.The company launches with two provider partners already onboard, including Cecelia Health, a recognized national virtual specialty care provider for chronic care management, and Advanced Metabolic Care & Research (AMCR), one of the leading endocrinology centers in Southern California serving thousands of
Read More
23andMe Scores FDA Clearance for Novel Cancer Immunotherapy Targeting NK Cells
What You Should Know:
- 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to as '1473), paving the way for the first human clinical trial of this promising new therapy.
- With FDA clearance secured, 23andMe plans to initiate a Phase 1 clinical trial in the first half of 2024. This initial study will evaluate the safety and
Read More
Community Health Systems Leverages Google Cloud’s Generative AI for Data Insights, Clinical Documentation
What You Should Know:
- Community Health Systems (CHS), a healthcare provider with 71 hospitals across 15 states announced the successful deployment of its clinical data to a secure, Fast Healthcare Interoperability Resources (FHIR)-based platform on Google Cloud.
- The deployment, coupled with the planned implementation of generative AI (gen AI) technologies, marks a significant step towards streamlining operations, improving patient care, and empowering healthcare professionals. By
Read More
Fabric Acquires Conversational AI Care Assistant GYANT
What You Should Know:
- Fabric, a leader in healthcare experience optimization, has announced the strategic acquisition of GYANT, a company specializing in conversational AI care assistants and patient engagement suites.
- The acquisition of GYANT positions Fabric as a leading force in the digital transformation of healthcare. Their comprehensive suite of solutions is already attracting progressive healthcare providers and innovators, like OSF Healthcare, who are looking to reimagine care
Read More
Talkspace, Bicycle Health Expands Access to Virtual Care for Patients with Opioid Use Disorder
What You Should Know:
Today, Talkspace, the largest telemedicine-based therapy provider covered by insurance in the nation, and Bicycle Health, the leading telemedicine-based program for opioid use disorder (OUD) treatment, have announced a partnership to enhance virtual care access for their respective patient bases. Through this collaboration, Talkspace patients gain increased access to specialized care for opioid use disorder, including medication for opioid use
Read More
Hospital Deploys ZeroEyes AI Gun Detection Solution
What You Should Know:
ZeroEyes, the creators of the only AI-based gun detection video analytics platform that holds the US Department of Homeland Security SAFETY Act Designation, today announced that its proactive gun detection and intelligent situational awareness solution has been deployed at JPS Health Network in Fort Worth, Texas to mitigate gun-related violence. Located in Tarrant County, the 582-bed hospital includes an acute care facility, outpatient care centers, and
Read More
Pediatrix Deploys AI-Powered Prenatal Care with Sonio, Streamlining Workflow and Enhancing Patient Experience
What You Should Know:
- Pediatrix Medical Group, a provider of specialized healthcare for women, children, and babies in the U.S., is making waves by deploying Sonio's AI-powered prenatal care solution.
- The innovative technology promises to revolutionize ultrasound workflow, improve quality assurance, and ultimately, deliver a better experience for both patients and providers.
Simplifying the Complexities of Prenatal Care
Traditional prenatal care workflows often involve multiple
Read More
PathAI Expands PathExplore Reach to 14 Cancer Types, Fueling Precision Oncology
What You Should Know:
- PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal.
- The expansion doubles the platform's reach, now covering 14 different cancer types, and further solidifies PathExplore as the leading tool for characterizing the tumor microenvironment (TME) from H&E-stained whole-slide images (WSIs).
Bridging the Gap in Cancer Research
Despite advances in cancer
Read More
